|Tel||+44 (0)1865 612635|
Richard Williams has worked at the Kennedy Institute of Rheumatology since 1989 and was a Senior Lecturer (2007-2011) and then Reader (2011-2012) at Imperial College London before joining the University of Oxford.
He is also a Visiting Lecturer at University College London, Queen Mary University of London and the London School of Hygiene and Tropical Medicine and was recently appointed as an Editor of Arthritis Research and Therapy.
He has established an internationally recognised reputation in translational research and his early studies were instrumental in the development of TNF blocking biologics.
He has carried out numerous projects with British and overseas industrial partners, including Merck, Pfizer, GSK, UCB, Schering, Celgene and J&J and has led an MRC DPFS project on rheumatoid arthritis.
McCann FE. et al, (2014), Arthritis & rheumatology (Hoboken, N.J.), 66, 2728 - 2738
Cribbs AP. et al, (2014), Arthritis & rheumatology (Hoboken, N.J.), 66, 2344 - 2354
Alzabin S. et al, (2012), Annals of the rheumatic diseases, 71, 1741 - 1748
Criado G. et al, (2009), Arthritis and rheumatism, 60, 1342 - 1351
Notley CA. et al, (2008), The Journal of experimental medicine, 205, 2491 - 2497
Hull DN. et al, (2016), Arthritis research & therapy, 18
Hull DN. et al, (2016), ARTHRITIS RESEARCH & THERAPY, 18
Bystrom J. et al, (2016), Cytokine
Kawalkowska J. et al, (2016), Scientific reports, 6
Kawalkowska JZ. et al, (2016), European journal of immunology, 46, 1246 - 1257